| Christopher A. Bunka |
Christopher A. Bunka is currently the Chairman & Chief Executive Officer at Lexaria Bioscience Corp. and the President & Chief Executive Officer at CAB Financial Services Ltd. His former positions include President & Chief Executive Officer at Secure Enterprise Solutions, Inc., Chairman, CEO, Secretary & Treasurer at Golden Aria Corp., Chairman, CEO, Secretary & Treasurer at Enertopia Corp., Independent Director at Defiance Silver Corp., and President at B.C. Ltd. |
| Nelson D. Cabatuan |
Nelson D. Cabatuan is currently the Chief Financial Officer at Lexaria Bioscience Corp. He previously worked as the Chief Accounting Officer, VP & Controller at Rigel Pharmaceuticals, Inc. from 2017 to 2020. Prior to that, he was a Senior Manager at Grant Thornton LLP from 2005 to 2008. Nelson also served as the Senior Vice President-Finance & Administration at Rain Oncology, Inc. from 2021 to 2023. He obtained his undergraduate degree from Pamantasan Ng Lungsod Ng Maynila in 1998. |
| John Martin Docherty |
John Martin Docherty is currently the President & Director of Lexaria Bioscience Corp. since 2015. He was previously the President & Director of PharmaDerm Laboratories Ltd. from 2004 to 2008 and the President & Chief Operating Officer of Helix BioPharma Corp. from 2012 to 2013. Mr. Docherty received his undergraduate and graduate degrees from the University of Toronto in 1993 and 1995, respectively. |
| William Edward McKechnie |
William Edward McKechnie is the founder of Advanced Technology For Food Manufacturing, which was founded in 2014. He is currently the Chairman of Davies Group of Co'S Corp. since 2005, Chairman of Foodstarter since 2017, Independent Director of Lexaria Bioscience Corp. since 2015, a Member-Governor of St. Jerome's University, and President of William Davies Consulting, Inc. He previously held positions as Chairman, Chief Executive & Financial Officer of Xtra-Gold Resources Corp. from 2003 to 2007, President & Chief Operating Officer of Maple Leaf Foods, Inc. from 1993 to 1996, and President & Owner of Humpty Dumpty Foods Ltd. |
| Catherine C. Turkel |
Catherine C. Turkel is an Independent Director at Lexaria Bioscience Corp. and the Prostate Cancer Research Institute. She previously worked as the Director of Drug Development & Regulatory Affairs at Cypros Pharmaceutical Corp., Vice President of Clinical Development at Allergan, Inc., Chief Development Officer at Otic Pharma Ltd., and President at Eledon Pharmaceuticals, Inc. Turkel holds an MBA from the University of California, Irvine, and doctorates from the University of the Pacific and Capella University LLC. |
| Albert L. Reese |
Albert L. Reese is an Independent Director at Lexaria Bioscience Corp. He previously worked as a Director at CommunityBank of Texas, CFO, Treasurer & Head-Investor Relations at ATP Oil & Gas Corp., and Chief Financial Officer at Harbert Energy Corp and Plumb Oil Co., Inc. He was also a Partner at Arnold, Reese & Swenson. Mr. Reese received his undergraduate degree from Texas A&M University in 1971 and his MBA from the University of Houston in 1977. |
| Nicholas W. Baxter |
Nicholas W. Baxter is the founder of Arawak Energy (UK) Ltd. (founded in 1985) and Arawak Energy Ltd. (founded in 1999). He held the title of Chief Operating Officer & Director at Arawak Energy Ltd. from 1999 to 2002. Mr. Baxter's current jobs include being the President & Chief Executive Officer at Rhino Biotech Ltd. since 2005, an Independent Director at Lexaria Bioscience Corp. since 2011, and an Independent Director at Jericho Energy Ventures, Inc. since 2011. Mr. Baxter obtained his undergraduate degree from The University of Liverpool in 1975. |
